| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
7.57 -0.12 (-0.02%) |
06-20 14:56 |
|
Open: |
7.83 |
Pre close: |
7.69 |
Target:
|
9.19 
|
|
High: |
7.84 |
Low: |
7.457 |
Resistance:
|
7.86
8.59
|
|
Volume: |
30,969 |
Market Cap: |
109M |
Support:
|
6.69
5.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.34
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
7.55 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
7.28 |
Stochastic Oscillator |
%K(14,3):
|
32.42 |
|
MA(250): |
8.30 |
%D(3): |
21.71 |
|
Average Volume(K) |
3-Month: |
2254
|
52-Week |
High:
|
11.34 |
|
10-Days: |
2348 |
Low: |
6.15 |
|
RSI |
RSI(14):
|
51.03 |
Change(%): |
1.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.770 |
Return on Equity (ttm) |
-44.8 |
Shares Out. (M) |
14.44 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-23.4 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
-1.1 |
% Held by Institutions |
1.90 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.128 |
Shares Short (K) |
166 |
|
Book Value (p.s.) |
5.080 |
EBITDA (p.s.) |
-0.547 |
P/E |
-9.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.61 |
P/S |
598217088.00 |
|
Operating Margin |
-442.90 |
Levered Free Cash Flow
(M) |
-5.08 |
P/CF |
-10.15 |
|
|
|
|
|
|
